comparemela.com

Latest Breaking News On - Congenital anomalies - Page 1 : comparemela.com

Reviewing ProKidney (NASDAQ:PROK) and Cabaletta Bio (NASDAQ:CABA)

ProKidney (NASDAQ:PROK – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk ProKidney has a beta of […]

Use of isotretinoin among girls and women of childbearing age and occurrence of isotretinoin-exposed pregnancies in Germany: A population-based study

Jonas Reinold and colleagues investigate how isotretinoin use has changed over a 15 year period in Germany and the potential for in-utero exposure.

Social Capital Group LLC Sells 1,700,000 Shares of ProKidney Corp (NASDAQ:PROK)

Social Capital Group LLC decreased its holdings in shares of ProKidney Corp. (NASDAQ:PROK – Free Report) by 12.8% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,573,000 shares of the company’s stock after selling 1,700,000 shares during the period. ProKidney makes up approximately 89.0% of Social Capital Group LLC’s portfolio, making the stock […]

Thalidomide survivors are receiving an apology for the pharmaceutical disaster that changed pregnancy medicine

The first report linking thalidomide to birth malformations was made by Australian doctor William McBride. The drug led to thousands of instances of pregnancy loss, neonatal deaths and disability.

ProKidney Corp (NASDAQ:PROK) Major Shareholder Sells $138,299 00 in Stock

ProKidney Corp (NASDAQ:PROK) Major Shareholder Sells $138,299 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.